<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8C3068E-F9B6-4EE7-96ED-6F14E65F3EF0"><gtr:id>A8C3068E-F9B6-4EE7-96ED-6F14E65F3EF0</gtr:id><gtr:name>Chartered Institution of Building Servic</gtr:name><gtr:address><gtr:line1>222 Balham High Road</gtr:line1><gtr:line2>London</gtr:line2><gtr:postCode>SW12 9BS</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8C3068E-F9B6-4EE7-96ED-6F14E65F3EF0"><gtr:id>A8C3068E-F9B6-4EE7-96ED-6F14E65F3EF0</gtr:id><gtr:name>Chartered Institution of Building Servic</gtr:name><gtr:address><gtr:line1>222 Balham High Road</gtr:line1><gtr:line2>London</gtr:line2><gtr:postCode>SW12 9BS</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B5AEDFEB-D8BD-48D6-A310-BDB32264656B"><gtr:id>B5AEDFEB-D8BD-48D6-A310-BDB32264656B</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Baldwin</gtr:surname><gtr:orcidId>0000-0001-7579-8844</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ014346%2F1"><gtr:id>419F1393-B359-40BA-92B5-D9BB01301EB4</gtr:id><gtr:title>Interrogating the molecular basis of aggregation inhibition by molecular chaperones</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/J014346/1</gtr:grantReference><gtr:abstractText>Proteins are the basic building blocks of all organisms. Over 100,000 different types are responsible for various functions such as moving muscles, digesting food, defending against infections or sending signals between different cells or other parts of the organism. They are all composed of only 20 different building blocks, called amino-acids, arranged in a sequential chain. The exact sequence of the protein is stored in our genes, and can be many hundreds or even thousands of blocks long, and they are produced inside cells as linear chains. In order for protein molecules to function, they must adopt a well defined 3D structure. The process by which the newly synthesised chain finds its 3D structure is called 'protein folding'. A family of proteins known as 'molecular chaperones' are present to facilitate the folding process. Biological organisms need correctly folded proteins in order to function optimally. 

Rather than always adopting their correct fold, protein chains however have an intrinsic tendency to cluster together and aggregate. The build up of aggregates in tissues together with the loss of function of the aggregating protein can lead to a set of diseases known as 'mis-folding diseases'. A wide range of pathologic human conditions, including neurodegenerative disorders Alzheimer's and Parkinson's diseases as well as type II diabetes and the prion diseases are mis-folding diseases. Such diseases as well as being some of the most feared in old age, place a larger financial burden on society than cancer and heart disease combined. At present, the fundamental roots of mis-folding disease are poorly understood.

A particular family of molecular chaperones, the sHSPs are found bound to aggregates removed post-mortem from Alzheimer's disease. Strikingly, they are able to stop proteins from aggregating in vitro, but we know very little about how they are able to do this. 

sHSPs naturally exist in an aggregated state that makes them intrinsically very hard to study. My proposed research is aimed at determining how they are able to prevent protein aggregation. To do this, I will take advantage of recent technological advances in three state-of-the-art methodologies - nuclear magnetic resonance spectroscopy, mass spectrometry and electron microscopy. Each is able to look at very different aspects of sHSPs, and the combination will make a powerful toolkit that I anticipate will lead to new insights into how sHSPs can prevent protein aggregation. By doing so, I hope to find new ways to look at developing therapeutic treatments for those suffering from mis-folding diseases.

The potential for these techniques to provide insights into biological systems is immense. A BBSRC David Phillips Fellowship will enable me bring the necessary expertise to conduct such studies in the UK. The research will be performed at the University of Oxford, a world leading centre of research. I am very excited to have the opportunity to enter this uniquely stimulating environment at the next stage of my career.</gtr:abstractText><gtr:technicalSummary>A wide range of human disorders including Alzhemier's and Parkinson's diseases are associated with a build up of potentially pathogenic protein aggregates in vivo. At least under normal circumstances, a family of molecular chaperones, the sHSPs are able to inhibit proteins from forming potentially pathogenic aggregates. These promiscuous chaperones reduce the aggregation rates of a wide range of misfolded proteins, but do not bind functional proteins. How they do this is far from certain, as they have proven highly recalcitrant to structural characterisation, primarily due to the wide range of oligomers they populate and the local dynamics that allow individual subunits to move between oligomers. My proposal is concerned with interrogating the mechanism by which these complex molecules are able to inhibit protein aggregation.

My proposal is to take advantage of the most recent developments in NMR that allow studies of conformational dynamics and interactions of large molecular assemblies at atomic resolution. I will complement information describing secondary/tertiary structure from NMR with MS and EM, techniques able to reveal the quaternary structure, shape and size of complexes under study. This hybrid methodology forms a tool box with which I can interrogate these otherwise biophysically intractable heterogeneous assemblies. 

This research will answer fundamental questions about how the chaperones recognise mis-folded protein states, and inhibit their aggregation. In doing so, it will shed light onto how biological organisms naturally hold aggregation at bay and reveal novel aspects of mis-folding diseases, the group of diseases that is rapidly becoming both the most costly in terms of health care and the most feared, in the developed world.</gtr:technicalSummary><gtr:potentialImpactText>The primary potential beneficiaries of my research in the longer term will be those in the wider public that suffer from mis-folding diseases such as senile dementia and those that live in fear that this condition will strike them in their old age. At present, there remain some very fundamental questions surrounding the process of protein aggregation and the biological mechanisms that have evolved to regulate it. Clearly the role of molecular chaperones is central to the body's aggregation defence network. The sHSPs are able to prevent and in some cases reverse aggregation in vitro. This is precisely the reason why I have chosen to study them at the start of my independent career. By delineating the molecular mechanism by which sHSPs can prevent protein aggregation I hope that my research will lead to novel insight into how we can combat, for example, neurodegenerative disorders.

Protein mis-folding diseases represent an enormous threat to our very quality of life, and the threat looms particularly as we age. One of the most feared conditions in old age is that of senile dementia, associated with neurodegenerative disorders. A recently published report from the World Alzheimer's society has revealed that there are 36 million cases worldwide of senility resulting from neurodegenerative conditions, costing the world's economy 1% of its GDP each year in care (&amp;pound;388 billion). By 2030 there are predicted to be 66 million, at an anticipated cost of &amp;pound;700 billion. The study concludes that dementia poses the most significant health and social crisis of the century. Such rapidly proliferating conditions are clearly a grave reality to an ever growing proportion of the total global population and a looming threat to an even greater proportion. Specifically in the UK, a study by Oxford University and the Alzheimer's Research Trust estimated that the total cost to our economy due to dementia is &amp;pound;23 billion p.a., exceeding that of &amp;pound;12 billion p.a. for Cancer and &amp;pound;8 billion p.r heart disease. Current treatments revolve around long term care, as there are no treatments at present that can deal with the cause of such conditions. Consequently, there is a clear public need for the biomedical sciences to produce quality research that can treat these disorders. I believe that in characterizing in detail how molecular chaperones are able to suppress protein aggregation in vitro, my proposed research will be helping to fulfill this need.

The research staff working on this project will be trained in molecular biology, protein expression, biophysics and applications of solution NMR to studies of structure, interactions and dynamics of proteins as well as rigorous interpretation of quantitative data. These are skills essential in many biological laboratories and companies large and small exploiting biotechnologies. In addition, establishing the research laboratory in the UK will lead to transfer of knowledge from Canada to the UK, enabling researchers access to the methodology of solution NMR of supra-molecular protein complexes up to 1MDa (Sprangers &amp;amp; Kay, Nature, 2007) and studying lowly populated protein states (Korzhnev et al, Science, 2010). The transfer of methodology will start immediately. I expect that the first publications will be submitted within two years from starting the research.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1124485</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Shire Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Shire UK</gtr:department><gtr:description>Shire</gtr:description><gtr:id>06FC06C4-A98D-4FCC-A59D-9CDAD89FFBFF</gtr:id><gtr:impact>A paper which is about to be submitted (Shire legal department are currently looking over it).</gtr:impact><gtr:outcomeId>56a0b8c3d36ab8.77933629-1</gtr:outcomeId><gtr:partnerContribution>They sent us materials.</gtr:partnerContribution><gtr:piContribution>By sharing materials and expertise, we have worked on investigating how one of their proteins, GCase prevents aggregation of alpha-Synuclein, a protein involved in Parkinson's disease.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chartered Institution of Building Services Engineers (CIBSE)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Methyl Assignments</gtr:description><gtr:id>6BCDD2F3-F330-476D-90BF-C033C73FEA96</gtr:id><gtr:impact>Nothing to date. This year (2016) should reveal outcomes.</gtr:impact><gtr:outcomeId>56a0b9ef10fa10.52353253-1</gtr:outcomeId><gtr:partnerContribution>They supply data and we analyse it.</gtr:partnerContribution><gtr:piContribution>We are working with these companies to analyse data describing protein/drug interactions involved with amyloid diseases. The analysis method was developed by work on a BBSRC grant, that is in the process of being awarded a patent. We seek to commercialise this.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Methyl Assignments</gtr:description><gtr:id>8A22C1F6-F8AE-46B6-BD9A-DAFDD62432CC</gtr:id><gtr:impact>Nothing to date. This year (2016) should reveal outcomes.</gtr:impact><gtr:outcomeId>56a0b9ef10fa10.52353253-3</gtr:outcomeId><gtr:partnerContribution>They supply data and we analyse it.</gtr:partnerContribution><gtr:piContribution>We are working with these companies to analyse data describing protein/drug interactions involved with amyloid diseases. The analysis method was developed by work on a BBSRC grant, that is in the process of being awarded a patent. We seek to commercialise this.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Methyl Assignments</gtr:description><gtr:id>3B96F937-B5E1-4324-9BEA-8E900592EA5F</gtr:id><gtr:impact>Nothing to date. This year (2016) should reveal outcomes.</gtr:impact><gtr:outcomeId>56a0b9ef10fa10.52353253-2</gtr:outcomeId><gtr:partnerContribution>They supply data and we analyse it.</gtr:partnerContribution><gtr:piContribution>We are working with these companies to analyse data describing protein/drug interactions involved with amyloid diseases. The analysis method was developed by work on a BBSRC grant, that is in the process of being awarded a patent. We seek to commercialise this.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>New NMR spectrometer</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>151/133</gtr:fundingRef><gtr:id>A14201C6-232B-4D5D-85DF-B4D7050C2BB5</gtr:id><gtr:outcomeId>56a0bd44a2c967.09024743</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>New electronics for NMR spectrometer</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>131/011</gtr:fundingRef><gtr:id>3B32081E-DB2F-4DC5-9033-E8D17626E816</gtr:id><gtr:outcomeId>56a0bd19863e52.95795740</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A method for biomolecular separation and modification using a biologically inspired set of reagents developed during a BBSRC project</gtr:description><gtr:grantRef>BB/J014346/1</gtr:grantRef><gtr:id>67F143BB-CCE5-4FFC-A321-B28AFEFBD10C</gtr:id><gtr:impact>None</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56a0bb5c3c6ef3.50166680</gtr:outcomeId><gtr:patentId>1518477.3</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>BIOMOLECULE SEPARATION AND MODIFICATION</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A method for assigning methylTROSY NMR spectra.</gtr:description><gtr:grantRef>BB/J014346/1</gtr:grantRef><gtr:id>FA7E41C5-07EC-434E-9EF9-A02E631886A3</gtr:id><gtr:impact>New collaborations, and more researchers both industrial and academic using our method.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c66ff5c51866.84519805</gtr:outcomeId><gtr:patentId>GB 1608969.0</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Method for assignment of methyl NMR spectra</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to assign methylTROSY NMR data.</gtr:description><gtr:id>A54D9962-1E67-4E43-BF08-BDA50255B514</gtr:id><gtr:impact>People have downloaded it and used it.</gtr:impact><gtr:outcomeId>58c66ee6635e69.56629908</gtr:outcomeId><gtr:title>MAGMA</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://magma.chem.ox.ac.uk/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Deconvolves mass spectrometry data. Highly useful for analysing complex heterogeneous mixtures.</gtr:description><gtr:id>8AA2DB23-FC82-49C8-9B2D-FB86721D4F20</gtr:id><gtr:impact>Has been downloaded many times. The native mass spectrometry community are giving us great feedback and are enjoying using it.</gtr:impact><gtr:outcomeId>56a0bc6b614d20.99666419</gtr:outcomeId><gtr:title>Unidec</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://unidec.chem.ox.ac.uk/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Software for analysis of mass spectrometry data. Design to show whether or not specific lipids bind membrane proteins.</gtr:description><gtr:id>C67AA649-68D6-46D5-A413-FBD52742CDF0</gtr:id><gtr:impact>It has been widely downloaded and used.</gtr:impact><gtr:outcomeId>58c6ba4fdbba94.82799137</gtr:outcomeId><gtr:title>PULSAR</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://pulsar.chem.ox.ac.uk</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to calculate the collision cross section of biomolecules. Useful for interpretting native ion mobility mass spectrometry data.</gtr:description><gtr:id>E3172F34-D9D9-499B-A15E-B19C09E6E8A8</gtr:id><gtr:impact>Has been adopted by the community.</gtr:impact><gtr:outcomeId>56a0bbf7276980.81366399</gtr:outcomeId><gtr:title>IMPACT</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://impact.chem.ox.ac.uk/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DA273EA5-AC0D-475E-829D-8C270748C6BE</gtr:id><gtr:title>Structural biology: Dynamic binding.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56a0b4fb296233.36149728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4993D7D9-C28F-4A02-ABCD-F3D0F246CAB9</gtr:id><gtr:title>Determination of an optimally sensitive and specific chemical exchange saturation transfer MRI quantification metric in relevant biological phantoms.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0138c64d17104e9f5521c9f5f058fc6"><gtr:id>e0138c64d17104e9f5521c9f5f058fc6</gtr:id><gtr:otherNames>Ray KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>58c66cc5a1cce8.53006625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A380BF8A-4665-4434-9DF7-622F22E6D9B3</gtr:id><gtr:title>Combining tandem mass spectrometry with ion mobility separation to determine the architecture of polydisperse proteins</gtr:title><gtr:parentPublicationTitle>International Journal of Mass Spectrometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aee340c87b4312c08587ce5b615a7ed6"><gtr:id>aee340c87b4312c08587ce5b615a7ed6</gtr:id><gtr:otherNames>Shepherd D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56a0b4f8a5d551.14125195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279DB85D-221F-44AA-B329-37F5DAA4C224</gtr:id><gtr:title>Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cf3a5a8edf15b212e94edb95bb32f8e"><gtr:id>6cf3a5a8edf15b212e94edb95bb32f8e</gtr:id><gtr:otherNames>Nott TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56a0b4f9147e83.93287233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97380EA2-E2C8-4544-9525-F04D81BA9445</gtr:id><gtr:title>Structural principles that enable oligomeric small heat-shock protein paralogs to evolve distinct functions.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfe33ae52012ac4f04b8ab07422f5e6a"><gtr:id>bfe33ae52012ac4f04b8ab07422f5e6a</gtr:id><gtr:otherNames>Hochberg GKA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5a981ea80e5713.08159779</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E2C83E-D1B8-4E10-B59D-01F8F733F6E5</gtr:id><gtr:title>Harnessing NMR relaxation interference effects to characterise supramolecular assemblies.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eed3ad99199ef20c7cb316f0ff71fcf"><gtr:id>9eed3ad99199ef20c7cb316f0ff71fcf</gtr:id><gtr:otherNames>Karunanithy G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>585d386b5bda19.00967814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BBB8133-F12E-4D6D-BBD9-B7521462A498</gtr:id><gtr:title>Accommodating Protein Dynamics in the Modeling of Chemical Crosslinks.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a9f4953285f3fd0af1e97a125c21b33"><gtr:id>5a9f4953285f3fd0af1e97a125c21b33</gtr:id><gtr:otherNames>Degiacomi MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>5a6f2cf2163763.10424801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34EDEE52-BFD6-4245-9204-FAA94CE2FE12</gtr:id><gtr:title>Membraneless organelles can melt nucleic acid duplexes and act as biomolecular filters.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cf3a5a8edf15b212e94edb95bb32f8e"><gtr:id>6cf3a5a8edf15b212e94edb95bb32f8e</gtr:id><gtr:otherNames>Nott TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>585d401136e084.70476090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2632BA44-E934-4FA1-8367-B2ACA086F2EC</gtr:id><gtr:title>Structural and hydrodynamic properties of an intrinsically disordered region of a germ cell-specific protein on phase separation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0b5702387e64ef7a66c0a96d44730da"><gtr:id>e0b5702387e64ef7a66c0a96d44730da</gtr:id><gtr:otherNames>Brady JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a6f55b748df80.23901643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7CA6626-8CC4-43AC-B661-5F901A7B8706</gtr:id><gtr:title>Measurement of the signs of methyl 13C chemical shift differences between interconverting ground and excited protein states by R(1?): an application to aB-crystallin.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular NMR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0925-2738</gtr:issn><gtr:outcomeId>56a0b4fab62461.29713620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDBC8D0C-454D-4EAE-BF88-30A2772B995F</gtr:id><gtr:title>Collision cross sections for structural proteomics.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16ebee0593a5c2f91904c0ecd1c4affb"><gtr:id>16ebee0593a5c2f91904c0ecd1c4affb</gtr:id><gtr:otherNames>Marklund EG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>56a0b4f879bee2.82786954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0305A6AB-EEF7-4F66-8020-A97F78344973</gtr:id><gtr:title>C-terminal interactions mediate the quaternary dynamics of aB-crystallin.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5af617ea60e2c9b76d7f8e51ccde511b"><gtr:id>5af617ea60e2c9b76d7f8e51ccde511b</gtr:id><gtr:otherNames>Hilton GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>56a0b4fa300e41.39193997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56F7B3C9-871F-4882-9539-7EE9D3A9ADC1</gtr:id><gtr:title>Proline isomerization in the C-terminal region of HSP27.</gtr:title><gtr:parentPublicationTitle>Cell stress &amp; chaperones</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6afbc0d9d682b3a4c624605daf8e16e0"><gtr:id>6afbc0d9d682b3a4c624605daf8e16e0</gtr:id><gtr:otherNames>Alderson TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1355-8145</gtr:issn><gtr:outcomeId>5a959cda88fbe2.59187827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4E9644-4F55-4905-800C-88FEFD7F1C5A</gtr:id><gtr:title>Quantifying the stabilizing effects of protein-ligand interactions in the gas phase.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e51686fe545b10732e914a906cdf08a"><gtr:id>6e51686fe545b10732e914a906cdf08a</gtr:id><gtr:otherNames>Allison TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56a0b4f941a681.33125537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C5858C4-3696-4672-A9D9-9A7745F16087</gtr:id><gtr:title>Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ef346aeead2484cf626622ed68af884"><gtr:id>5ef346aeead2484cf626622ed68af884</gtr:id><gtr:otherNames>Marty MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>56a0b4f84a19f9.35590278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3044A2B4-E6F3-4E7D-8B72-4719D4CBB761</gtr:id><gtr:title>Membrane proteins bind lipids selectively to modulate their structure and function.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ecf32f01331b2e5eaeb0d56e5f21e27"><gtr:id>4ecf32f01331b2e5eaeb0d56e5f21e27</gtr:id><gtr:otherNames>Laganowsky A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56a0b4f99aca77.14345676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62804B30-36A2-45FC-AA50-E1359A370B8E</gtr:id><gtr:title>Automatic Assignment of Methyl-NMR Spectra of Supramolecular Machines Using Graph Theory.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a69995d4de509f51ff0ce34229542a6"><gtr:id>5a69995d4de509f51ff0ce34229542a6</gtr:id><gtr:otherNames>Priti?anac I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>5a2fcc5408a787.75703859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5788DFE8-C746-44AD-9913-28AC02206445</gtr:id><gtr:title>The structured core domain of &amp;Icirc;&amp;plusmn;B-crystallin can prevent amyloid fibrillation and associated toxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a656d2424d4b33f2799044f13f09fa4"><gtr:id>8a656d2424d4b33f2799044f13f09fa4</gtr:id><gtr:otherNames>Hochberg GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56a0b4f9c9e5c7.63899888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24BF6DCD-C4A2-4DB1-98EB-FB8EE6A4B20A</gtr:id><gtr:title>An exact solution for R2,eff in CPMG experiments in the case of two site chemical exchange.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn><gtr:outcomeId>56a0b4f9715f54.76973719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55DB266A-A426-4FE8-9868-04105DFA57B5</gtr:id><gtr:title>Small heat-shock proteins: paramedics of the cell.</gtr:title><gtr:parentPublicationTitle>Topics in current chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5af617ea60e2c9b76d7f8e51ccde511b"><gtr:id>5af617ea60e2c9b76d7f8e51ccde511b</gtr:id><gtr:otherNames>Hilton GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-3-642-34551-7</gtr:isbn><gtr:issn>0340-1022</gtr:issn><gtr:outcomeId>56a0b4fa5e8591.25759794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68E5CD25-31FA-4608-8672-AB3A6C8C77E5</gtr:id><gtr:title>Twisting transition between crystalline and fibrillar phases of aggregated peptides.</gtr:title><gtr:parentPublicationTitle>Physical review letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e2c0c056be8b0d6b1bc3f028e869671"><gtr:id>2e2c0c056be8b0d6b1bc3f028e869671</gtr:id><gtr:otherNames>Knowles TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0031-9007</gtr:issn><gtr:outcomeId>56a0b4fb881683.25533865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E37302-EC22-4FC8-8483-BFF8543B3D74</gtr:id><gtr:title>Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain diversity.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28997722e762a000d9d172529c952d05"><gtr:id>28997722e762a000d9d172529c952d05</gtr:id><gtr:otherNames>Wright TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58c66c1dd71291.09904707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7B2D3D-551D-43B4-B4B6-D6612B643706</gtr:id><gtr:title>Monitoring the Disassembly of Virus-like Particles byF-NMR.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57f53c8681e679eabf9e31020ac9da12"><gtr:id>57f53c8681e679eabf9e31020ac9da12</gtr:id><gtr:otherNames>Leung RLC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>5a2fcdd984af84.66725852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE050FA0-2BFB-4918-B1BA-5F04D2756165</gtr:id><gtr:title>Investigating the mechanisms of amylolysis of starch granules by solution-state NMR.</gtr:title><gtr:parentPublicationTitle>Biomacromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1525-7797</gtr:issn><gtr:outcomeId>56a0b4f8d7ef56.32983790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC80B7CE-0D88-45E9-A9FD-CAD12681081A</gtr:id><gtr:title>The morphology of decorated amyloid fibers is controlled by the conformation and position of the displayed protein.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a58a75ac876297da2de807eff988b54f"><gtr:id>a58a75ac876297da2de807eff988b54f</gtr:id><gtr:otherNames>Forman CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>56a0b4fb5d3c52.97844356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98FC43BB-4105-42A7-ADDC-4EE24F1E4B88</gtr:id><gtr:title>The role of interfacial lipids in stabilizing membrane protein oligomers.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cf0923b5facbcc824e81a9395fcdc60"><gtr:id>9cf0923b5facbcc824e81a9395fcdc60</gtr:id><gtr:otherNames>Gupta K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58c66c568c0ef4.38148715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>825BDAC7-CA87-46EA-819A-90C229906EAF</gtr:id><gtr:title>Dissecting heterogeneous molecular chaperone complexes using a mass spectrum deconvolution approach.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06a567d0162fb859b4090d7c2056fb5e"><gtr:id>06a567d0162fb859b4090d7c2056fb5e</gtr:id><gtr:otherNames>Stengel F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>56a0b4fa8b2766.72741912</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08435F1D-DA89-4464-B8FE-BCD85098B948</gtr:id><gtr:title>An R(1?) expression for a spin in chemical exchange between two sites with unequal transverse relaxation rates.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular NMR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0925-2738</gtr:issn><gtr:outcomeId>56a0b4fa028bd9.13347700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51ED162B-3724-4662-95F7-AC13A31D7201</gtr:id><gtr:title>Probing dynamic conformations of the high-molecular-weight aB-crystallin heat shock protein ensemble by NMR spectroscopy.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca094508868230152aa78ff9a85ec81"><gtr:id>6ca094508868230152aa78ff9a85ec81</gtr:id><gtr:otherNames>Baldwin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>56a0b4fae5ee20.43612050</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J014346/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02FE9751-1497-4DFD-B349-D4A9C96538E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biophysics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>7DA052B9-38AC-4F23-88FA-66C8DEB08B81</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Organelles &amp; components</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>8A1414BC-05E5-4D38-BDC1-A953EE4AF4E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein chemistry</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9A14218E-A5F9-4EB2-AAC1-C04E62C49637</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein folding / misfolding</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3493671D-A4CF-4197-90A7-3CCFBE1C0627</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools for the biosciences</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>